Skip to main content
Premium Trial:

Request an Annual Quote

Norak Licenses Transfluor Technology to Merck

NEW YORK, Oct. 6 (GenomeWeb News) - Norak Biosciences has licensed its Transfluor technology to drug maker Merck for use in its G protein-coupled receptor drug discovery efforts.


Financial terms of the pact were not disclosed. The pact is the second between the firms, following a 2002 agreement granting Merck limited access to Transfluor, which is used to screen potential drug candidates against GPCR targets.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more